Looking closer at MCI, the complex forerunner to dementia

May 11, 2017 by Gabrielle Dunlevy, University of New South Wales
Looking closer at MCI, the complex forerunner to dementia
Credit: Shutterstock

Researchers looking at the trajectory of Mild Cognitive Impairment (MCI) say examining specific subtypes is critical in identifying individuals at high risk of developing dementia.

MCI is defined as having noticed cognitive decline which is confirmed by objective tests in people who are functioning well.

MCI is associated with a higher risk of dementia and for some people is an intermediate stage between normal cognitive ageing and dementia.

But there are many reasons why a person's cognition might have declined such as depression, infection or reaction to medications.

So, it is not surprising that many individuals with MCI "revert" to normal cognition. What is less well known is that people who revert to normal from MCI have an increased risk of re-transitioning to MCI or progressing to dementia.

Dr Liesbeth Aerts of the Dementia Collaborative Research Centre at UNSW says the relevance of reversion for progression risk depends on the MCI subtype.

In a paper published in the journal Neurology, four biennial assessments of 705 elderly people in the UNSW Centre for Healthy Brain Ageing Sydney Memory and Ageing Study showed reversion from MCI was common.

Almost half of the people who had MCI at the start of the study (46.5%) tested as "normal" at least once during follow-up assessment.

But risk of progression to dementia was only lower for those who reverted from amnestic MCI, a subtype of MCI in which memory is affected.

Dr Aerts, the paper's lead author, says it highlights the importance of subtype specificity.

"We need to be mapping these cognitive problems much better, because just saying 'MCI' is not enough to really know about dementia risk," she says.

Longitudinal follow-up is crucial to determining which individuals with MCI are at of developing dementia.

"In our study people's performance on fluctuated or zig-zagged over time," Dr Aerts says.

"Our results highlight that we need better assessment over time. Snapshot assessments should be considered in a larger perspective.

"Before, no one was thinking of reversion, we were only trying to capture people on decline."

A bigger picture issue is the limitations of the cognitive tests, and the important role that biomarkers (biological indicators of dementia, for example changes in brain chemicals and imaging) will play in the future.

Changes in the brain occur long before the first symptoms become apparent, so being able to measure those will be crucial to identify in the earliest stages of dementia.

"Researchers are shifting the frame to studying to what happens long before the onset of dementia in the hope of stopping the degenerative process in the brain in its tracks before takes hold."

Explore further: Review links albuminuria to cognitive impairment, dementia

More information: Effects of MCI subtype and reversion on progression to dementia in a community sample. Neurology. DOI: 10.1212/WNL.0000000000004015

Related Stories

Review links albuminuria to cognitive impairment, dementia

February 13, 2017
(HealthDay)—Albuminuria is associated with cognitive impairment, dementia, and cognitive decline, according to a review published online Feb. 2 in the Journal of the American Geriatrics Society.

Late-life depression associated with prevalent mild cognitive impairment, increased risk of dementia

December 31, 2012
Depression in a group of Medicare recipients ages 65 years and older appears to be associated with prevalent mild cognitive impairment and an increased risk of dementia, according to a report published Online First by Archives ...

Protein in urine linked to increased risk of memory problems, dementia

December 14, 2016
People who have protein in their urine, which is a sign of kidney problems, may also be more likely to later develop problems with thinking and memory skills or even dementia, according to a meta-analysis published in the ...

Delirium could accelerate dementia-related mental decline

January 18, 2017
When hospitalised, people can become acutely confused and disorientated. This condition, known as delirium, affects a quarter of older patients and new research by UCL and University of Cambridge shows it may have long-lasting ...

Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

November 2, 2016
Dementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzheimer's disease and Parkinson's disease, a ...

Cognitive decline 'reversed' in one in four people

March 28, 2013
(Medical Xpress)—One in four elderly people with mild cognitive impairment – a precursor to dementia – naturally 'reverts' to normal cognition, research from the University of New South Wales (UNSW) shows.

Recommended for you

Rate of dementia on the decline—but beware of growing numbers

April 17, 2018
The good news? The rate of older Americans with dementia is on the decline.

Research offers potential insight into Alzheimer's disease

April 16, 2018
Slightly elevated beta-amyloid levels in the brain are associated with increased activity in certain brain regions, according to a new study from the Center for Vital Longevity (CVL) at The University of Texas at Dallas.

Americans with a college education live longer without dementia and Alzheimer's

April 16, 2018
Education gives people an edge in their later years, helping them to keep dementia at bay and their memories intact, a new USC-led study has found.

Evidence mounts for Alzheimer's, suicide risks among youth in polluted cities

April 13, 2018
A University of Montana researcher and her collaborators have published a new study that reveals increased risks for Alzheimer's and suicide among children and young adults living in polluted megacities.

Improving brain function in Alzheimer's disease mouse model

April 11, 2018
Using two complementary approaches to reduce the deposits of amyloid-beta in the brain rather than either approach alone improved spatial navigation and memory in a mouse model of Alzheimer's disease. These findings suggest ...

Sleepless nights show ties to Alzheimer's risk

April 10, 2018
Even one night of lost sleep may cause the brain to fill with protein chunks that have long been linked to the development of Alzheimer's disease, a new study warns.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.